You are here

New Jersey

Merck to move global headquarters, returning to an old home

Merck to move global headquarters, returning to an old home

Endpoints

Flag link:

Top Companies in Pharm Country Ranked by Revenue

Top Companies in Pharm Country Ranked by Revenue

BioSpace

Bristol-Myers Squibb

Ovid Therapeutics

Flag link:

Pharm Country's Biotech and Pharma Industry Flourishes Thanks to Innovative Leadership

Pharm Country's Biotech and Pharma Industry Flourishes Thanks to Innovative Leadership

BioSpace

Flag link:

New Jersey Finally Finalizes its “Gift” Ban Amendments – Exempts Educational Events

New Jersey Finally Finalizes its “Gift” Ban Amendments – Exempts Educational Events

Policy Med

physician gifts

Flag link:

The top 10 medical device states: Everything you need to know

The top 10 medical device states: Everything you need to know

Mass Device

Flag link:

New Jersey Sues Janssen Pharmaceuticals Over Two Opioid Drugs

New Jersey Sues Janssen Pharmaceuticals Over Two Opioid Drugs

BioSpace

Flag link:

Could Publicly Funded Medtech Face Price Controls in NJ?

Could Publicly Funded Medtech Face Price Controls in NJ?

Medical Devices and Diagnostics Industry

Flag link:

With Millions At Stake, New Jersey Won't Accept Junk Science Against Pharma Companies

With Millions At Stake, New Jersey Won't Accept Junk Science Against Pharma Companies

Forbes

Flag link:

Teva, lured by $40M tax break, packs its bags for New Jersey HQ move

Teva, lured by $40M tax break, packs its bags for New Jersey HQ move

Fierce Pharma

Teva Pharmaceutical

Flag link:

What’s a move to New Jersey worth? For Teva’s U.S. headquarters, $40M in tax breaks

What’s a move to New Jersey worth? For Teva’s U.S. headquarters, $40M in tax breaks

Fierce Pharma

Teva Pharmaceutical

Flag link:

BIO18: Merck's Ebola lessons, New Jersey vies for biotech jobs

BIO18: Merck's Ebola lessons, New Jersey vies for biotech jobs

Biopharma Dive

Flag link:

New Jersey jury hits BD subsidiary Bard with $33m pelvic mesh verdict

New Jersey jury hits BD subsidiary Bard with $33m pelvic mesh verdict

Mass Device

Becton Dickinson

Bard Avaulta vaginal sling

Flag link:

New Jersey Finalizes New Limits on Pharmaceutical Manufacturer Gifts and Payments to Prescribers

New Jersey Finalizes New Limits on Pharmaceutical Manufacturer Gifts and Payments to Prescribers

FDA Law Blog

physician payments

Flag link:

New NJ rules would curb payments to doctors from drug companies

New NJ rules would curb payments to doctors from drug companies

NJ.com

physician payments

Flag link:

NJ AG goes after high-prescribing doctor on Insys Therapeutics' speakers bureau

NJ AG goes after high-prescribing doctor on Insys Therapeutics' speakers bureau

Seeking Alpha

INSYS Therapeutics

physician payments

Flag link:

Allergan to consolidate operations in NJ

Allergan to consolidate operations in NJ

BioPharma Dive

Flag link:

New Jersey appeals court upholds $11m pelvic mesh decision against J&J

New Jersey appeals court upholds $11m pelvic mesh decision against J&J

Mass Device

Flag link:

Big Pharma still a big deal for NJ economy, despite cost cuts

Big Pharma still a big deal for NJ economy, despite cost cuts

Fierce Pharma

Bristol-Myers Squibb

Flag link:

Residents want to sue Roche before it gives up New Jersey campus

Residents want to sue Roche before it gives up New Jersey campus

Fierce Pharma

Flag link:

Bristol-Myers blueprints a 2,500-worker campus in New Jersey

Bristol-Myers blueprints a 2,500-worker campus in New Jersey

Fierce Biotech

Bristol-Myers Squibb

Flag link:

Pages